Carrier-mediated Transport
Carrier-mediated Transport - Related Videos
01:06
Carrier-Mediated Transport
0 Views •
2024
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient. Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
01:21
Carrier Transport
0 Views •
2024
The generation of electrical current in semiconductors is fundamentally driven by two mechanisms: drift and diffusion. These processes are essential for the functionality and performance of semiconductor-based devices. Drift Current: The drift of charge carriers is started by an external electric field (E). Charged particles, such as electrons and holes, experience an acceleration between collisions with lattice atoms. For electrons, this results in a drift velocity (vd) given by: Where μe is...
01:19
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
0 Views •
2025
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input. Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
01:16
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
0 Views •
2026
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:24
Electron Carriers
0 Views •
2019
Electron carriers can be thought of as electron shuttles. These compounds can easily accept electrons (i.e., be reduced) or lose them (i.e., be oxidized). They play an essential role in energy production because cellular respiration is contingent on the flow of electrons. Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
FAQs
Competition and saturation make transporter capacity a central determinant of drug exposure. When several molecules seek the same carrier, they can interfere with one another; as available carriers become occupied, increasing substrate concentration may no longer produce a proportional increase in transport. These properties help explain why coadministered compounds can alter drug concentrations and why dose-related effects may become nonlinear.
Passive and active carrier-mediated transport differ in what supplies the driving force. Passive movement follows a concentration gradient, whereas active movement is coupled either to cellular energy or to an ion gradient. This distinction matters because the relevant gradient or energy source can determine whether a molecule continues to move across a membrane as concentrations on the two sides change.
Genetic variation in transporters can change the amount of drug moved across a membrane. Because transport systems participate in absorption, tissue entry, and renal or hepatic secretion, an inherited difference may influence drug concentrations at more than one stage of disposition. The resulting variability can contribute to differences in therapeutic response or toxicity among individuals receiving the same drug.
Carrier-mediated transport is especially consequential at the intestinal epithelium, where it can influence drug entry after oral administration. It also affects movement into tissues and contributes to secretion by the kidneys and liver. Examining these locations connects membrane transport with the pharmacologic processes that determine how much drug is absorbed, where it distributes, and how it is eliminated.
To interpret a possible transporter-based drug interaction, pharmacologists consider whether two compounds depend on the same carrier and whether transport becomes limited by carrier occupancy. A competing compound may change the amount transported, which can shift drug concentrations. The relevant concern is not merely altered movement at a membrane, but possible changes in therapeutic efficacy or toxicity.
Studies of these systems can link a transport process to absorption, distribution, or elimination rather than treating drug concentration as a purely passive consequence of diffusion. Altered movement across an intestinal barrier, into tissue, or through renal and hepatic secretion can help explain concentration changes. This interpretation provides context for variable responses, interactions, efficacy, and toxicity.